SAN DIEGO (AP) — SAN DIEGO (AP) — Fate Therapeutics Inc. (FATE) on Monday reported a loss of $44.1 million in its fourth quarter.
The San Diego-based company said it had a loss of 45 cents per share.
The results beat Wall Street expectations. The average estimate...
